Gait Adaptation Study
for Aging
1 location in Newark
Sponsor: Rutgers, The State University of New Jersey
Sex: All·Age: 18 - 80·Accepts healthy volunteers
Code: NCT07660601·EARLY_Phase 1·Recruiting·Listed Jun 22, 2026
Paid Clinical Trials in Newark, NJ
As of August 2026, 115 paid clinical trials are recruiting in Newark, New Jersey. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Newark offers studies at sites including Newark Beth Israel Medical Center for conditions such as Heart Failure, Heart Diseases, Breast Cancer, Cardiovascular Diseases. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Newark
Trials by drug in Newark
Filter results
Filter results
Newly added in Newark
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
for HIV Infections
Sites in Newark +34 more locations
Sponsor: ViiV Healthcare
Sex: All·Age: 12+
Code: NCT07650916·Phase 3·Recruiting·Listed Jun 16, 2026
106 clinical trials
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)
for Hepatitis
Drug: Larsucosterol
Sites in Newark, Camden +82 more locations
Sponsor: Bausch Health Americas, Inc.
Sex: All·Age: 18+
Code: NCT07428538·Phase 3·Recruiting·Listed Feb 2026
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
for Cardiovascular Disease
Drug: Olpasiran
Sites in Newark, Irvington +197 more locations
Sponsor: Amgen
Sex: All·Age: 50 - 105
Code: NCT07136012·Phase 3·Recruiting·Listed Aug 2025
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
for Breast Neoplasms
Drug: Pumitamig
Sites in Newark, Livingston +62 more locations
Sponsor: BioNTech SE
Sex: All·Age: 18+
Code: NCT07173751·Phase 3·Recruiting·Listed Sep 2025
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
for Proteinuric Kidney Disease
Sites in Newark, Hackensack +164 more locations
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All·Age: 10 - 65
Code: NCT05312879·Phase 2, Phase 3·Recruiting·Listed Apr 2022
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
for HER2-positive Breast Cancer
Sites in Newark +21 more locations
Sponsor: Jazz Pharmaceuticals
Sex: All·Age: 18+
Code: NCT07102381·Phase 2·Recruiting·Listed Aug 2025
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
for Heart Failure With Preserved Ejection Fraction
Sites in Newark, Somerset +108 more locations
Sponsor: Amgen
Sex: All·Age: 18 - 99
Code: NCT07037459·Phase 3·Recruiting·Listed Jun 2025
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
for Coronavirus Disease (COVID-19)
Sites in Newark, Teaneck +59 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT06667700·Phase 3·Recruiting·Listed Oct 2024
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
for Lumbar Spinal Stenosis
Sites in Newark, Harrison +2341 more locations
Sponsor: Stryker Instruments
Sex: All·Age: 18+
Code: NCT03072927·Recruiting·Listed Mar 2017
Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature
for Peripheral Vascular Diseases
Sites in Newark, Hackensack +36 more locations
Sponsor: Boston Scientific Corporation
Sex: All·Age: 18+
Code: NCT04674969·Recruiting·Listed Dec 2020
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
for Heart Failure
Sites in Newark, Hackensack +55 more locations
Sponsor: Abbott Medical Devices
Sex: All·Age: 18+
Code: NCT06526195·Recruiting·Listed Jul 2024
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
for Sickle Cell Disease
Drug: Etavopivat
Sites in Newark +44 more locations
Sponsor: Novo Nordisk A/S
Sex: All·Age: 12+
Code: NCT06612268·Phase 3·Recruiting·Listed Sep 2024
CCM OPEN HF Registry
for Heart Failure
Sites in Newark, Hackensack +26 more locations
Sponsor: Impulse Dynamics
Sex: All·Age: 18+
Code: NCT07112924·Recruiting·Listed Aug 2025
SuperSaturated Oxygen Comprehensive Observational Registry
for STEMI - ST Elevation Myocardial Infarction
Sites in Newark, Jersey City +23 more locations
Sponsor: TherOx
Sex: All·Age: 18 - 80
Code: NCT06438315·Recruiting·Listed May 2024
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
for Functional Mitral Regurgitation
Sites in Newark, Edison +49 more locations
Sponsor: Cardiac Dimensions, Inc.
Sex: All·Age: 18+
Code: NCT03142152·Recruiting·Listed May 2017
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
for Cardiovascular Diseases
Sites in Newark +36 more locations
Sponsor: BrioHealth Solutions, Inc.
Sex: All·Age: 18 - 100
Code: NCT06310031·Recruiting·Listed Mar 2024
JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization
for AAA
Sites in Newark +24 more locations
Sponsor: Endologix
Sex: All·Age: 21+
Code: NCT05064540·Recruiting·Listed Oct 2021
PARTNER 3 Trial - Aortic Valve-in-Valve
for Aortic Stenosis
Sites in Newark +28 more locations
Sponsor: Edwards Lifesciences
Sex: All·Age: All ages
Code: NCT03003299·Recruiting·Listed Dec 2016
A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
for Human Immunodeficiency Virus (HIV)
Sites in Newark +22 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 16+·Accepts healthy volunteers
Code: NCT07044297·Phase 3·Recruiting·Listed Jun 2025
Evaluation of the Safety and Effectiveness of ARTIA Reconstructive Tissue Matrix Breast Reconstruction (ADORA) in Adult Participants
for Breast Reconstruction
Sites in Newark +16 more locations
Sponsor: AbbVie
Sex: Female·Age: 18+
Code: NCT06575192·Phase 3·Recruiting·Listed Aug 2024
A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of VLU (VALUE)
for Venous Leg Ulcer (VLU)
Sites in Newark +12 more locations
Sponsor: MediWound Ltd
Sex: All·Age: 18+
Code: NCT06568627·Phase 3·Recruiting·Listed Aug 2024
A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
for End Stage Renal Disease (ESRD)
Sites in Newark +19 more locations
Sponsor: W.L.Gore & Associates
Sex: All·Age: 18 - 90
Code: NCT04671771·Recruiting·Listed Dec 2020
Comparison of Transforming Powder Dressing to NPIAP Recommended Standard of Care Therapies in Stage 2, 3 and 4 Pressure Injuries
for Pressure Ulcers Stage II
Sites in Newark +12 more locations
Sponsor: ULURU Inc.
Sex: All·Age: 18 - 85·Accepts healthy volunteers
Code: NCT05496296·Recruiting·Listed Aug 2022
Clinical Study of SNK01 in Participants With Moderate Alzheimer's Disease
for Moderate Alzheimer Disease
Sites in Newark +5 more locations
Sponsor: NKGen Biotech, Inc.
Sex: All·Age: 40 - 85
Code: NCT06189963·Phase 1, Phase 2·Recruiting·Listed Jan 2024
A Randomized Controlled Phase II Trial of STIMULAN VG vs Standard of Care (SoC) for the Treatment of Osteomyelitis Associated With Stage IV Pressure Ulcers.
for Pressure Ulcer, Stage IV
Sites in Newark +8 more locations
Sponsor: Biocomposites Ltd
Sex: All·Age: 18+
Code: NCT06283979·Phase 2·Recruiting·Listed Feb 2024
Optimize Neoadjuvant Therapy in HER2-Positive Early-Stage Breast Cancer
for HER2-positive Early-stage Breast Cancer
Sites in Newark, Elizabeth +5 more locations
Sponsor: Rutgers, The State University of New Jersey
Sex: All·Age: 18 - 90
Code: NCT07402473·Phase 2·Recruiting·Listed Feb 2026
Pelashield™ PainGuard™ vs Restrata® in HS Surgery
for Hidradenitis Suppurativa (HS)
1 location in Newark
Sponsor: Rutgers, The State University of New Jersey
Sex: All·Age: 18+
Code: NCT07316192·Recruiting·Listed Jan 2026
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
for Advanced Endometrial Carcinoma
Drug: Bevacizumab
Sites in Newark, Paramus +237 more locations
Sponsor: National Cancer Institute (NCI)
Sex: Female·Age: 18+
Code: NCT07198074·Phase 3·Recruiting·Listed Sep 2025
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
for Breast Cancer
Sites in Newark, Elizabeth +1098 more locations
Sponsor: NRG Oncology
Sex: Female·Age: 18 - 60
Code: NCT05879926·Phase 3·Recruiting·Listed May 2023
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
for Stage III Colon Cancer
Sites in Newark, Elizabeth +913 more locations
Sponsor: NRG Oncology
Sex: All·Age: 18+
Code: NCT05174169·Phase 2, Phase 3·Recruiting·Listed Dec 2021
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
for Anatomic Stage II Breast Cancer AJCC v8
Sites in Newark, Elizabeth +777 more locations
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All·Age: 18+
Code: NCT05812807·Phase 3·Recruiting·Listed Apr 2023
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
for Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Sites in Newark, Jersey City +98 more locations
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18+
Code: NCT07195734·Phase 2·Recruiting·Listed Sep 2025
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
for Head and Neck Squamous Cell Carcinoma
Sites in Newark, Jersey City +464 more locations
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All·Age: 18+
Code: NCT02734537·Phase 2·Recruiting·Listed Apr 2016
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
for Locally Advanced Cervical Adenocarcinoma
Sites in Newark, Jersey City +303 more locations
Sponsor: National Cancer Institute (NCI)
Sex: Female·Age: 18+
Code: NCT07061977·Phase 3·Recruiting·Listed Jul 2025
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
for Anatomic Stage II Breast Cancer AJCC v8
Drug: Durvalumab
Sites in Newark, Elizabeth +525 more locations
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18+
Code: NCT06058377·Phase 3·Recruiting·Listed Sep 2023
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
for Clear Cell Renal Cell Carcinoma
Sites in Newark, Summit +406 more locations
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All·Age: 18+
Code: NCT06661720·Phase 3·Recruiting·Listed Oct 2024
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
for Ovarian Carcinoma
Sites in Newark, Jersey City +479 more locations
Sponsor: NRG Oncology
Sex: Female·Age: 35 - 50
Code: NCT04251052·Recruiting·Listed Jan 2020
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
for Childhood Extracranial Germ Cell Tumor
Sites in Newark, Paterson +385 more locations
Sponsor: Children's Oncology Group
Sex: All·Age: All ages
Code: NCT03067181·Phase 3·Recruiting·Listed Mar 2017
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
for Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Drug: Nivolumab
Sites in Newark, Elizabeth +376 more locations
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 5 - 60
Code: NCT05675410·Phase 3·Recruiting·Listed Jan 2023
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
for Locally Advanced Lung Non-Small Cell Carcinoma
Sites in Newark, Jersey City +444 more locations
Sponsor: NRG Oncology
Sex: All·Age: 18+
Code: NCT05624996·Phase 3·Recruiting·Listed Nov 2022
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
for Locally Advanced Urothelial Carcinoma
Sites in Newark, Livingston +154 more locations
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18+
Code: NCT06524544·Phase 3·Recruiting·Listed Jul 2024
Top Research Study Locations in Newark
Researchers run research studies in Newark, NJ at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Newark Beth Israel Medical Center | Heart Diseases, Heart Failure, Anatomic Stage II Breast Cancer AJCC v8 | 31 |
| Rutgers New Jersey Medical School | Stage III Laryngeal Cancer AJCC v8, Stage III Lip and Oral Cavity Cancer AJCC v8, Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8 | 21 |
| University Hospital | Postoperative Pain, Breast Neoplasms, Cervical Cancer Screening | 8 |
| Rutgers School of Dental Medicine | Acute Pain, Apical Periodontitis, Bacteremia | 7 |
| RWJBarnabas Health - Newark Beth Israel Medical Center | Cardiac Toxicity, Early-stage Breast Cancer, Gastro-Intestinal Cancer | 5 |
| Rutgers University - Newark | Nicotine Use Disorder, Behavior, Spatial Navigation | 4 |
| Rutgers School of Health Professions | Cerebral Palsy (CP), Dysarthria, Guanfacine | 2 |
| Rutgers University | Atherosclerosis of Extremities, Inflammation, Older Adults (65 Years and Older) | 2 |
| Rutgers University Hospital | Hepatic Encephalopathy, Liver Cirrhosis, Opioid Use Disorder | 2 |
| Saint Michaels Medical Center | Cardiovascular Disease, Heart Failure With Mildly Reduced Ejection Fraction, Heart Failure With Preserved Ejection Fraction | 2 |
| Saint Michael's Medical Center | Acute Myocardial Infarction, Coronavirus Disease (COVID-19) | 2 |
| 31786, New Jersey Medical School Clinical Research Center CRS | Acute HIV Infection | 1 |
| Cancer Center Initiative | Breast Neoplasms, Colorectal Neoplasms, Gastro-Intestinal Intraepithelial Neoplasia | 1 |
| GSK Investigational Site | HIV Infections | 1 |
| Infectious Disease Practice- Rutgers University | HIV Infections | 1 |
| Medical Oncology Hematology Associates | Breast Cancer, HER2-positive Breast Cancer | 1 |
| New Jersey Community Research Initiative | AIDS (Acquired Immune Deficiency Syndrome), HIV, Suicidal Ideation and Behavior | 1 |
| New Jersey Medical School Clinical Research Center CRS (31786) | HIV Infection, Menopause | 1 |
| Newark Beth Israel | Aortic Stenosis, Aortic Stenosis, Severe | 1 |
| Newark Beth Israel MC | Sickle Cell Disease | 1 |
| Newark Beth Israel Medical Center - Hemophilia Center | Bleeding Disorder, Connective Tissue Disorder, Factor IX Deficiency | 1 |
| RWJB Infectious Disease | AIDS (Acquired Immune Deficiency Syndrome), HIV, Suicidal Ideation and Behavior | 1 |
| RWJBarnabas Health Newark Beth Israel Medical Center | Breast Neoplasms, Colorectal Neoplasms, Gastro-Intestinal Intraepithelial Neoplasia | 1 |
| Rutgers | Chronic Renal Disease, End Stage Renal Disease (ESRD), Hemodialysis | 1 |
| Rutgers - New Jersey Medical School / University Hospital | Hydrocephalus, Intraventricular Hemorrhage of Prematurity | 1 |
Active & Upcoming Studies in Newark (2026)
Recruiting trials in Newark grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (36 active studies)
- Developing and Implementing HPV SCREENED · Rutgers, The State University of New Jersey
- Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer · Phase 2 · National Cancer Institute (NCI)
Neurology & pain (12 active studies)
- Jaw Muscle Pain Post Wisdom Molar Surgery · Phase 2 · Rutgers, The State University of New Jersey
- Impact of RADA16 Use on Outcomes Following Tonsillectomy in Children · Phase 2 · Rutgers, The State University of New Jersey
Cardiovascular (9 active studies)
- Evaluating the Use of Prehospital Lung Ultrasound in EMS: A Multicenter Pilot Study · Rutgers, The State University of New Jersey
- CCM OPEN HF Registry · Impulse Dynamics
HIV / STI (6 active studies)
- Menopausal HT for Women Living With HIV (HoT) · Phase 4 · Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
- A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study) · Phase 2 · ViiV Healthcare
Diabetes & metabolic (2 active studies)
- Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity · Phase 3 · Amgen
- A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma · Phase 2 · Children's Oncology Group
Vaccines (1 active study)
- A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023) · Phase 3 · Merck Sharp & Dohme LLC
Common conditions studied in Newark
- Heart Failure (5 active studies)
- Heart Diseases (4 active studies)
- Breast Cancer (3 active studies)
- Cardiovascular Diseases (3 active studies)
- Sickle Cell Disease (3 active studies)
- Stage III Laryngeal Cancer AJCC v8 (3 active studies)
Leading research sponsors in Newark
- Rutgers, The State University of New Jersey
- National Cancer Institute (NCI)
- Children's Oncology Group
- NRG Oncology
- Alliance for Clinical Trials in Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in Newark?
There are approximately 115 recruiting clinical trials in Newark, New Jersey listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Newark pay participants?
Most recruiting trials in Newark compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Newark?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Newark?
The most common conditions under active study in Newark include Heart Failure (5), Heart Diseases (4), Breast Cancer (3), Cardiovascular Diseases (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Newark?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Newark on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Newark?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Newark?
Recruiting research sites in Newark include Newark Beth Israel Medical Center, Rutgers New Jersey Medical School, University Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Newark right now?
The largest active categories in Newark are Cancer & tumors (36), Neurology & pain (12), Cardiovascular (9). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
Browse more clinical trials
Other cities in New Jersey
New Brunswick, NJ(337)Middletown, NJ(315)Basking Ridge, NJ(312)Montvale, NJ(305)Hackensack, NJ(299)Morristown, NJ(146)Camden, NJ(104)Toms River, NJ(70)East Brunswick, NJ(58)Livingston, NJ(58)Neptune City, NJ(57)Summit, NJ(52)West Orange, NJ(46)Paramus, NJ(45)Cherry Hill, NJ(43)Sewell, NJ(43)Jersey City, NJ(40)Englewood, NJ(39)Marlton, NJ(39)Long Branch, NJ(35)Ridgewood, NJ(34)Voorhees Township, NJ(34)Teaneck, NJ(33)Piscataway, NJ(30)Somerset, NJ(30)Paterson, NJ(28)Hamilton, NJ(23)Pennington, NJ(23)Somerville, NJ(23)Edison, NJ(22)Lakewood, NJ(20)Princeton, NJ(20)Eatontown, NJ(17)Flemington, NJ(17)Florham Park, NJ(17)East Hanover, NJ(16)Bridgewater, NJ(15)Moorestown, NJ(15)Elizabeth, NJ(13)Bloomfield, NJ(12)Freehold, NJ(12)Plainsboro, NJ(11)Somers Point, NJ(11)Sparta, NJ(10)East Orange, NJ(9)East Windsor, NJ(9)Mullica Hill, NJ(9)Pompton, NJ(9)Red Bank, NJ(9)Vineland, NJ(9)West Long Branch, NJ(9)Brick, NJ(8)Hackettstown, NJ(8)Newton, NJ(8)Warren Township, NJ(8)Belleville, NJ(7)Browns Mills, NJ(7)Palisades Park, NJ(7)Pomona, NJ(7)Springfield, NJ(7)